EcoDrugPlus

Matrix Metallopeptidase 2

Ensembl ID : ENSCAFG00020003742
Gene Symbol: MMP2
3 Cross references
210 Possible Orthologues:

Matrix Metallopeptidase 3

Ensembl ID : ENSCAFG00020009376
Gene Symbol: MMP3
3 Cross references
500 Possible Orthologues:

Matrix Metallopeptidase 8

Ensembl ID : ENSCAFG00020009478
Gene Symbol: MMP8
3 Cross references
111 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSCAFG00020014189
Gene Symbol: MMP9
3 Cross references
216 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSCAFG00020002763
Gene Symbol: MTOR
3 Cross references
224 Possible Orthologues:

Melanocortin 3 Receptor

Ensembl ID : ENSCAFG00020021920
Gene Symbol: MC3R
3 Cross references
139 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSCAFG00020020041
Gene Symbol: MC4R
3 Cross references
229 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSCAFG00020000162
Gene Symbol: MTNR1A
1 Cross references
216 Possible Orthologues:

Melatonin Receptor 1b

Ensembl ID : ENSCAFG00020016646
Gene Symbol: MTNR1B
1 Cross references
107 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSCAFG00020005383
Gene Symbol: MME
2 Cross references
227 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSCAFG00020023202
Gene Symbol: METAP2
3 Cross references
230 Possible Orthologues:

Microtubule Associated Protein Tau

Ensembl ID : ENSCAFG00020026861
Gene Symbol: MAPT
3 Cross references
226 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).